Additionally, SMARCA4 recruited by PRMT1-mediated H4R3me2a enhances EGFR signaling and TNS4 expression in colorectal cancer, with elevated PRMT1 or SMARCA4 levels positively correlating with increased EGFR and TNS4 expression and decreased overall survival [84]. This evidence concerns the gene EGFR and colorectal cancer.